Search results for "Cardiovascular Disease"
Cytisinicline shows promise for smoking cessation in industry-funded trial
In a phase 3 randomized controlled trial, both six- and 12-week courses of cytisinicline, an investigational drug, led to higher rates of continuous smoking abstinence compared with placebo.
https://immattersacp.org/weekly/archives/2023/07/18/1.htm
18 Jul 2023
CTA-detected coronary artery disease associated with increased risk for myocardial infarction
Danish researchers used computed tomography angiography (CTA) to diagnose obstructive coronary atherosclerosis in 9,533 asymptomatic patients ages 40 years or older without known cardiovascular disease.
https://immattersacp.org/weekly/archives/2023/03/28/2.htm
28 Mar 2023
Individualize behavioral counseling in those without CVD risk factors, USPSTF says
In an update consistent with its 2017 recommendation, the U.S. Preventive Services Task Force (USPSTF) recommended that clinicians individualize the use of behavioral counseling interventions to promote a healthy diet and physical activity in adults without risk factors for cardiovascular disease (CVD).
https://immattersacp.org/weekly/archives/2022/08/02/4.htm
2 Aug 2022
MKSAP Quiz: Motivating lifestyle change
A 28-year-old man is evaluated during a follow-up visit for hypertension and diabetes mellitus. He works two jobs and eats fast food for most meals. Which of the following is the most appropriate management?
https://immattersacp.org/weekly/archives/2023/03/21/3.htm
21 Mar 2023
A1c predicts cardiovascular disease, death in nondiabetics
A1c predicts cardiovascular disease, death in nondiabeticsGuidelines suggest more informed consent for prostate cancer screening
https://immattersacp.org/weekly/archives/2010/03/09/1.htm
9 Mar 2010
Nonsugar sweeteners should not be used for weight loss, WHO guideline states
The World Health Organization (WHO) cited a lack of evidence suggesting that short-term use of nonsugar sweeteners affected body weight or other measures of adiposity, as well as possible long-term undesirable effects on noncommunicable diseases and death.
https://immattersacp.org/weekly/archives/2023/05/23/2.htm
23 May 2023
Low-dose aspirin associated with 20% increase in risk of anemia among older adults
Analysis of a randomized trial of aspirin in healthy older patients found significantly increased risk of anemia, faster decline in hemoglobin concentrations, and greater decline in ferritin levels with aspirin versus placebo.
https://immattersacp.org/weekly/archives/2023/06/20/1.htm
20 Jun 2023
Temporary weight management programs may have long-term cardiometabolic benefits
Trial participants who completed behavioral weight management programs had long-term reductions in systolic blood pressure, cholesterol levels, and HbA1c level relative to comparators, but weight regain reduced these differences over time, a systematic review and meta-analysis found.
https://immattersacp.org/weekly/archives/2023/04/04/2.htm
4 Apr 2023
Oldest patients least likely to receive statins despite potential benefits, study finds
Patients older than age 75 years were less likely to receive moderate- or high-intensity statins than those ages 65 to 75 years despite their higher incidence of atherosclerotic cardiovascular disease.
https://immattersacp.org/weekly/archives/2021/09/21/4.htm
21 Sep 2021
Discontinuing primary preventive aspirin didn't appear to increase mortality risk
Regular aspirin users who were switched to placebo in a randomized trial did not have increased risk of all-cause mortality or cardiovascular disease events compared with those who continued aspirin, but the findings of the post hoc analysis were inconclusive.
https://immattersacp.org/weekly/archives/2022/03/15/2.htm
15 Mar 2022